Johnson & Johnson
The timing could not have been more suitable for Cairo to host Africa Health ExCon. The ExCon in Egypt, the beating heart of Africa, discussed ways to strengthen healthcare systems and saw Janssen Pharmaceutical Companies of Johnson & Johnson emphasizing its confidence in the growth of the Egyptian market as the country continues to invest in boosting healthcare systems and treatment delivery in hospitals.
Cairo International Airport received on Wednesday 3,688,500 doses of the AstraZeneca and Johnson & Johnson coronavirus vaccine, Acting Health Minister Khaled Abdel Ghaffar said.
Egypt’s Health Ministry said that 933 new coronavirus cases were detected, upping the total number of confirmed cases reported in the country since the beginning of the outbreak to 331,017.
Egypt’s Health Minister Hala Zayed announced Monday receiving the third shipment of Johnson & Johnson vaccine including 1,058,400 million doses.
The President advisor for health and prevention affairs Mohamed Awad Taj El-Din said Monday that Egypt will be receiving 25 million doses of Johnson & Johnson vaccine over the coming four months.
Minister of Health and Population Hala Zayed announced that 100,224 citizens were vaccinated against Coronavirus on Thursday.
Cairo international airport received, Monday the first patch of Johnson & Johnson Vaccine against coronavirus.
Egypt’s Health and Population Minister Hala Zayed announced, Wednesday finalizing all needed documents as a final step to receive the shipment of two Covid-19 vaccines [AstraZeneca and Johnson & Johnson], which will arrive in Egypt next week.
President Sisi has recommended the necessity of providing the citizens with the vaccine.
1.7 million doses of the AstraZenka vaccine will be received on May 9 from International Federation of Pharmaceutical Wholesalers (Gavi).
Johnson & Johnson International Pharmaceutical Industries injected LE 125 million in new investments in Egypt during 2019.
The verdict, in California Superior Court in Oakland, marks the latest defeat for the healthcare conglomerate facing more than 13,000 talc-related lawsuits nationwide.
Johnson & Johnson failed to persuade a Missouri trial judge to set aside a July verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s Baby Powder.
J&J is the second largest shareholder of the Japanese firm and owns a 19.9 percent stake through its affiliate.
J&J says the documents present no such evidence, but merely show the company’s caution.
The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines.
